CYCLO THERAPEUTICS INC (CYTH)

US23254X2018 - Common Stock

1.4  +0.03 (+2.19%)

News Image
4 days ago - InvestorPlace

CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024

Cyclo Therapeutics just reported results for the first quarter of 2024.

News Image
2 months ago - BusinessInsider

CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclo Therapeutics (NASDAQ:CYTH) just reported results for the fourth quarter o...

News Image
2 months ago - InvestorPlace

CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023

Cyclo Therapeutics just reported results for the fourth quarter of 2023.

News Image
5 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investments

News Image
7 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Company positions itself to generate value for its stockholders by curtailing expenses while increasing investment in strategic opportunities

News Image
8 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, CYTH, AMTI, EBC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
8 months ago - Seeking Alpha

Applied Molecular stock falls on merger with Cyclo Therapeutics

Applied Molecular Transport (AMTI) and Cyclo Therapeutics (CYTH) announced a merger agreement on Thursday whereby Applied Molecular (AMTI). Read more here.